BMP2K Knockout Jurkat Polyclonal Cells comprise a CRISPR/Cas9-edited polyclonal knockout cell population targeting the BMP2K gene in the human Jurkat T-lymphocyte line. This gene-disrupted model enables comprehensive loss-of-function analysis of BMP2K within a physiologically relevant immune context, bypassing clonal selection artifacts. The heterogeneous polyclonal format preserves population diversity and facilitates robust assessments of gene ablation on T cell signaling and endocytic processes. Researchers can utilize these cells to dissect BMP2K-dependent molecular events without the limitations inherent to single-cell-derived clones.
Jurkat cells are an immortalized T lymphocyte line originating from an acute T cell leukemia patient, widely employed as a model for T cell receptor signaling, apoptosis, and lymphocyte activation. Their transformed phenotype, rapid proliferation, and well-characterized signaling networks render them exceptionally suitable for genetic perturbation studies. As suspension cells derived from a leukemic background, they provide a tractable system to explore oncogenic pathways and immune regulation mechanisms in a human cellular context.
BMP2K (bone morphogenetic protein-2-inducible kinase) is a serine/threonine kinase transcriptionally upregulated by BMP-2 ligand via BMP receptors type I/II and SMAD transcription factors. It governs clathrin-mediated endocytosis by directly interacting with and phosphorylating key endocytic components, including clathrin heavy chain, the AP-2 adaptor complex, and dynamin. Functionally, BMP2K integrates BMP, Wnt, and MAPK/ERK signaling, acting upstream of SMAD1/5/8 to fine-tune signal transduction through receptor internalization and trafficking. Additionally, BMP2K interacts with HIV-1 Nef, linking it to host-pathogen dynamics and endosomal sorting.
In Jurkat T cells, knockout of BMP2K is predicted to impair clathrin-coated pit formation and cargo internalization, thereby altering surface expression of receptors such as BMP receptors and possibly modulating Wnt or MAPK/ERK cascades. This disruption can affect T cell activation thresholds, proliferation rates, and cytokine secretion profiles, making the model highly relevant for T cell acute lymphoblastic leukemia (T-ALL) research and for deciphering endocytic control of immune responses. The polyclonal knockout population offers a practical, reproducible tool for studying these mechanisms without monoclonal biases.
These BMP2K knockout cells are applicable to diverse experimental workflows, including Western blot analysis of BMP2K and phospho-SMAD1/5/8, RT-qPCR assessment of BMP-2-responsive genes, flow cytometric profiling of surface receptor levels, transferrin uptake assays to monitor clathrin-mediated endocytosis, cell proliferation studies, and drug sensitivity screening. They support investigations into BMP signaling in T lymphocytes, endocytosis in immune function, cancer cell biology, and neurological disease models. For further technical details and validation data, please contact Ascent Research.
